CRISPR THERAPEUTICS AG (CRSP)
CH0334081137 - Common Stock
ChartMill assigns a Buy % Consensus number of 74% to CRSP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 87.55. This target is 51.79% above the current price.
CRSP was analyzed by 35 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about CRSP.
In the previous month the buy percentage consensus was at a similar level.
CRSP was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-18 | Citigroup | Maintains | Buy -> Buy |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-06 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-26 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-02-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-02-22 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-02-22 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-22 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-21 | Needham | Maintains | Buy -> Buy |
| 2024-02-15 | Wolfe Research | Initiate | Peer Perform |
| 2023-12-11 | TD Cowen | Downgrade | Market Perform -> Underperform |
| 2023-12-11 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-12-11 | Needham | Maintains | Buy -> Buy |
| 2023-12-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-12-11 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-11 | Truist Securities | Maintains | Buy -> Buy |
| 2023-12-08 | Mizuho | Reiterate | Buy -> Buy |
| 2023-12-08 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-12-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-13 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-11-07 | Needham | Maintains | Buy -> Buy |
| 2023-11-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-11-01 | Needham | Reiterate | Buy -> Buy |
| 2023-10-30 | Needham | Reiterate | Buy -> Buy |
| 2023-10-17 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-09-27 | Mizuho | Initiate | Buy |
| 2023-08-18 | Citigroup | Upgrade | Neutral -> Buy |
| 2023-08-17 | Citigroup | Upgrade | Neutral -> Buy |
| 2023-08-14 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-08-10 | Oppenheimer | Reiterate | Outperform -> Outperform |